Wang Jing, Cao Qiancheng, Gao Minjie, Pan Yiru, Chen Yanan, Cao Yifei, Han Shufen, Yan Xiao, Xu Xianrong, Fang Xuexian, Lian Fuzhi
Department of Nutrition and Toxicology, School of Public Health, Hangzhou Normal University, Hangzhou, China.
Engineering Research Center of Mobile Health Management System, Ministry of Education, Hangzhou, China.
Sci Rep. 2025 Mar 12;15(1):8587. doi: 10.1038/s41598-025-88872-x.
Dietary phytoestrogens have been suggested to provide protection against numerous age-related diseases. However, their effects on biological aging remain unclear. In this study, we cross-sectionally investigated the relationship between urinary phytoestrogen levels and indicators of biological aging using data from 7,981 adults who participated in the National Health and Nutrition Examination Survey 1999-2010. Urinary concentrations of six phytoestrogens, including four isoflavones and two enterolignans, were measured using high-performance liquid chromatography (HPLC)-tandem mass spectrometry (MS) or HPLC-atmospheric pressure photoionization-tandem MS, and standardized using urinary creatinine. Three indicators of biological age (BA), namely the Klemera-Doubal method biological age (KDM-BA), phenotypic age (PA), and homeostatic dysregulation (HD), were derived from 12 clinical biomarkers, advanced-BAs were calculated to quantify the differences between individuals' BAs and chronological age, and individuals with all positive advanced-BAs were defined as accelerated-aging. Weighted linear regression analysis showed that after adjusting for demographic and lifestyle factors and history of chronic diseases, elevated urinary total phytoestrogen and enterolignans were significantly associated with less advanced-KDM, advanced-PA, and advanced-HD, whereas elevated urinary isoflavones was significantly associated with less advanced-KDM and advanced-PA but not with advanced-HD. Weighted logistic regression showed that higher urinary levels of total phytoestrogen (highest Q4 vs. lowest Q1: OR = 0.60, 95%CI: 0.44, 0.80; P-trend = 0.002) and enterolignans (Q4 vs. Q1: OR = 0.59, 95%CI: 0.45, 0.76; P-trend < 0.001) were significantly associated with lower odds of accelerated-aging, but this was not significant for isoflavones (Q4 vs. Q1: OR = 0.78, 95%CI: 0.60, 1.08; P-trend = 0.05). Subgroup analyses showed that negative associations were attenuated in non-overweight/obese participants and current cigarette smokers. In conclusion, higher levels of urinary phytoestrogens are related to markers of slower biological aging, suggesting an anti-aging effect of higher dietary phytoestrogen consumption, which warrants further investigations in longitudinal or interventional settings.
膳食植物雌激素被认为可以预防多种与年龄相关的疾病。然而,它们对生物衰老的影响仍不清楚。在本研究中,我们利用1999 - 2010年参加美国国家健康和营养检查调查的7981名成年人的数据,对尿植物雌激素水平与生物衰老指标之间的关系进行了横断面研究。使用高效液相色谱(HPLC)-串联质谱(MS)或HPLC -大气压光电离 -串联质谱法测定了六种植物雌激素的尿浓度,包括四种异黄酮和两种肠内木脂素,并使用尿肌酐进行标准化。从12种临床生物标志物得出了三个生物年龄(BA)指标,即克莱梅拉 - 杜巴尔法生物年龄(KDM - BA)、表型年龄(PA)和内环境失调(HD),计算了高级生物年龄以量化个体生物年龄与实际年龄之间的差异,所有高级生物年龄均为正值的个体被定义为加速衰老。加权线性回归分析表明,在调整了人口统计学和生活方式因素以及慢性病病史后,尿总植物雌激素和肠内木脂素升高与KDM - BA进展较慢、PA进展较慢和HD进展较慢显著相关,而尿异黄酮升高与KDM - BA进展较慢和PA进展较慢显著相关,但与HD进展无关。加权逻辑回归显示,尿总植物雌激素水平较高(最高四分位数Q4与最低四分位数Q1相比:OR = 0.60,95%CI:0.44,0.80;P趋势 = 0.002)和肠内木脂素水平较高(Q4与Q1相比:OR = 0.59,95%CI:0.45,0.76;P趋势 < 0.001)与加速衰老几率较低显著相关,但异黄酮并非如此(Q4与Q1相比:OR = 0.78,95%CI:0.60,1.08;P趋势 = 0.05)。亚组分析表明,在非超重/肥胖参与者和当前吸烟者中,负相关减弱。总之,尿植物雌激素水平较高与生物衰老较慢的标志物有关,这表明较高的膳食植物雌激素摄入量具有抗衰老作用,这值得在纵向或干预性研究中进一步探讨。